Industry / Bulgaria
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Significant Growth For Drug Market
March 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
BMI has revised its forecasts for the Bulgarian drug market after new figures were released by IMS Health. We now believe the market reached a value of US$970mn in 2007 after growing by 12%. By 2012, total sales should reach US$1.76mn, representing 2.4% of GDP.